TADALAFIL
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-908 -
Package NDC
71610-908-04 -
Package NDC
71610-908-06 -
Package NDC
71610-908-12 -
Package NDC
71610-908-39 -
Package NDC
71610-908-52 -
Application number
ANDA210609 -
SPL ID
35a64ceb-88bf-d4ed-e063-6394a90a7799 -
SPL set ID
351de7c2-98bf-7c88-e063-6294a90ad811 -
UNII
742SXX0ICT -
RxCUI
484814
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- tadalafil
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TADALAFIL",
"splId": "35a64ceb-88bf-d4ed-e063-6394a90a7799",
"labels": [
{
"setId": "351de7c2-98bf-7c88-e063-6294a90ad811",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=351de7c2-98bf-7c88-e063-6294a90ad811",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=351de7c2-98bf-7c88-e063-6294a90ad811"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "4 TABLET in 1 BOTTLE (71610-908-04)",
"package_ndc": "71610-908-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20250516"
},
{
"sample": false,
"description": "6 TABLET in 1 BOTTLE (71610-908-06)",
"package_ndc": "71610-908-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20250516"
},
{
"sample": false,
"description": "12 TABLET in 1 BOTTLE (71610-908-12)",
"package_ndc": "71610-908-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20250516"
},
{
"sample": false,
"description": "1440 TABLET in 1 BOTTLE (71610-908-39)",
"package_ndc": "71610-908-39",
"identifierStatus": "well-formed",
"marketing_start_date": "20250513"
},
{
"sample": false,
"description": "18 TABLET in 1 BOTTLE (71610-908-52)",
"package_ndc": "71610-908-52",
"identifierStatus": "well-formed",
"marketing_start_date": "20250516"
}
],
"productId": "71610-908_35a64ceb-88bf-d4ed-e063-6394a90a7799",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "71610-908",
"deaSchedule": null,
"genericName": "tadalafil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TADALAFIL",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA210609",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241127",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175599",
"N0000020026"
],
"unii": [
"742SXX0ICT"
],
"rxcui": [
"484814"
],
"spl_set_id": [
"351de7c2-98bf-7c88-e063-6294a90ad811"
],
"pharm_class_epc": [
"Phosphodiesterase 5 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Phosphodiesterase 5 Inhibitors [MoA]"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-908_35a64ceb-88bf-d4ed-e063-6394a90a7799"